Voyager Therapeutics names new CEO
This article was originally published in Scrip
Executive Summary
Interim president of R&D at Voyager Therapeutics, Dr Steven Paul, has been promoted to chief executive officer of the company. Dr Paul has been interim president since the company's launch in February 2014. Dr Paul is also a partner at venture capital firm Third Rock Ventures. He succeeds interim CEO Mark Levin, also a partner at Third Rock, who will become chair of Voyager's board of directors.